Thus, from the above tests, it was noted that reducing FOSL2 results in lower cell proliferation, migration, and invasion in U87 MG and U251 MG cell lines, indicating that FOSL2 could enhance glioma advancement. The gene discussed is FOSL2; the disease is central nervous system cancer.